ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study.

Michael Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.